
Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income countries, a move hailed as a potential gamechanger in the fight against the AIDS epidemic.
Trending
- Lens keep Ligue 1 title hopes alive with comeback win over Toulouse
- Global politics felt at Candidates chess tournaments
- Chris Martin loves her. Yungblud thinks she’s a rockstar: Meet the eightysomething vocal coach essential to the stars
- Why Your Paycheck Feels Smaller
- US jury rules Live Nation is illegal monopoly
- The Dog Stars Trailer Finds Jacob Elordi In Survival Mode
- Kanye West concert canceled in Poland
- A cultural stroll through the French Caribbean island of Martinique
